Review Article: High-Throughput Affinity-Based Technologies for Small-Molecule Drug Discovery

High-throughput affinity-based technologies are rapidly growing in use as primary screening methods in drug discovery. In this review, their principles and applications are described and their impact on small-molecule drug discovery is evaluated. In general, these technologies can be divided into 2 groups: those that detect binding interactions by measuring changes to the protein target and those that detect bound compounds. Technologies detecting binding interactions by focusing on the protein have limited throughput but can reveal mechanistic information about the binding interaction; technologies detecting bound compounds have very high throughput, some even significantly higher than current high-throughput screening technologies, but offer limited information about the binding interaction. In addition, the appropriate use of affinity-based technologies is discussed. Finally, nanotechnology is predicted to generate a significant impact on the future of affinity-based technologies. (Journal of Biomolecular Screening 2009:1157-1164)

• Publication year

  2009

• Venue

  Journal of biomolecular screening

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1177/1087057109350114PMID 19822881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of Allosteric PIF‐Pocket Ligands for PDK1 using NMR‐Based Fragment Screening and 1H‐15N TROSY Experiments

  2009cited by this paper
• Design, synthesis and selection of DNA-encoded small-molecule libraries.

  2009cited by this paper
• Inhibition and binding kinetics of the hepatitis C virus NS3 protease inhibitor ITMN-191 reveals tight binding and slow dissociative behavior.

  2009cited by this paper
• Fragment-Based Screening Using Surface Plasmon Resonance Technology

  2009cited by this paper
• Direct Screening of Natural Product Extracts Using Mass Spectrometry

  2008cited by this paper
• Multiplex sequencing of plant chloroplast genomes using Solexa sequencing-by-synthesis technology

  2008cited by this paper
• Nanoscale affinity chip interface for coupling inhibition SPR immunosensor screening with Nano-LC TOF MS.

  2008cited by this paper
• Screening of DHFR-binding drugs by MALDI-TOFMS

  2008cited by this paper
• Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library.

  2008cited by this paper
• Throughput and efficiency of a mass spectrometry-based screening assay for protein—Ligand binding detection

  2008cited by this paper
• Comparison of Miniaturized Time-Resolved Fluorescence Resonance Energy Transfer and Enzyme-Coupled Luciferase High-Throughput Screening Assays to Discover Inhibitors of Rho-Kinase II (ROCK-II)

  2008cited by this paper
• Fragment-Based Approach to Drug Lead Discovery

  2008cited by this paper
• Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms

  2008cited by this paper
• The Future of High-Throughput Screening

  2008cited by this paper
• High-throughput sequencing allows the identification of binding molecules isolated from DNA-encoded chemical libraries

  2008cited by this paper
• Protein recognition and denaturation by self-assembling fragments on a DNA quadruplex scaffold.

  2007cited by this paper
• Isolation of high-affinity trypsin inhibitors from a DNA-encoded chemical library.

  2007cited by this paper
• Application of fragment screening by X-ray crystallography to beta-secretase.

  2007cited by this paper
• Affinity selection-mass spectrometry screening techniques for small molecule drug discovery.

  2007cited by this paper
• Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.

  2007cited by this paper
• Label-Free High-Throughput Functional Lytic Assays

  2007cited by this paper
• An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF

  2006cited by this paper
• Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis.

  2006cited by this paper
• Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes

  2006cited by this paper
• Quadruplex DNA: sequence, topology and structure

  2006cited by this paper
• Studies of small molecule interactions with protein phosphatases using biosensor technology.

  2006cited by this paper
• Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.

  2006cited by this paper
• Discovery and Characterization of Orthosteric and Allosteric Muscarinic M2 Acetylcholine Receptor Ligands by Affinity Selection-Mass Spectrometry

  2006cited by this paper
• Hit and lead identification: Integrated technology-based approaches

  2006cited by this paper
• Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.

  2005cited by this paper
• Determining the optimal size of small molecule mixtures for high throughput NMR screening

  2005cited by this paper
• Chemical genetics to chemical genomics: small molecules offer big insights.

  2005cited by this paper
• Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.

  2005cited by this paper
• Kinetic studies of small molecule interactions with protein kinases using biosensor technology.

  2005cited by this paper
• Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes.

  2005cited by this paper
• Label-free detection of small-molecule-protein interactions by using nanowire nanosensors.

  2005cited by this paper
• SpeedScreen: The “Missing Link” between Genomics and Lead Discovery

  2004cited by this paper
• Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.

  2004cited by this paper
• Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery.

  2004influential reference
• Chemical Genomics

  2004cited by this paper
• DNA-Templated Organic Synthesis and Selection of a Library of Macrocycles

  2004cited by this paper
• An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries: Discovery of a novel antagonist of E. coli dihydrofolate reductase

  2004cited by this paper
• Label-Free Assays on the BIND System

  2004cited by this paper
• Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.

  2003cited by this paper
• High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility.

  2003cited by this paper
• Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface‐ and solution‐based biophysical methods

  2002cited by this paper
• A Strategy for High-Throughput Assay Development Using Leads Derived from Nuclear Magnetic Resonance-Based Screening

  2002cited by this paper
• High Throughput Screening: Methods and Protocols

  2002cited by this paper
• Integration of NMR and high-throughput screening.

  2002cited by this paper
• Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline

  2002cited by this paper
• Transport characteristics of peptides and peptidomimetics: II. Hydroxyethylamine bioisostere-containing peptidomimetics as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.

  2001cited by this paper
• Kinetics of small molecule inhibitor binding to p38 kinase.

  2001cited by this paper
• High-density miniaturized thermal shift assays as a general strategy for drug discovery.

  2001cited by this paper
• Characterization of a Set of HIV-1 Protease Inhibitors Using Binding Kinetics Data from a Biosensor-Based Screen

  2000cited by this paper
• Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins

  2000cited by this paper
• Thermodynamic and kinetic studies of the formation of triple helices between purine-rich deoxyribo-oligonucleotides and the promoter region of the human c-src proto-oncogene.

  1998cited by this paper
• One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules

  1997cited by this paper
• Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates.

  1992cited by this paper
• Missing link

  1989cited by this paper

• Chemical biology research in RIKEN NPDepo aimed at agricultural applications

  2025cites this paper
• Rational Design Strategies in DNA-Encoded Libraries for Drug Discovery.

  2025cites this paper
• Protein Engineering Paving the Way for Next-Generation Therapies in Cancer

  2025cites this paper
• Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug Discovery

  2024cites this paper
• Integrative computational approaches for discovery and evaluation of lead compound for drug design

  2024cites this paper
• Affinity selection mass spectrometry speeding drug discovery.

  2023cites this paper
• Inhibition of Replication Fork Formation and Progression: Targeting the Replication Initiation and Primosomal Proteins

  2023cites this paper
• Biomacromolecule-Assisted Screening for Reaction Discovery and Catalyst Optimization.

  2022cites this paper
• Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications

  2021cites this paper
• Solving the Competitive Binding Equilibria Between Many Ligands: Application to High-Throughput Screening and Affinity Optimization.

  2020cites this paper
• Application of Machine Learning Techniques in Drug-Target Interactions Prediction.

  2020cites this paper
• Intracellular Antibody Delivery Mediated by Lipids, Polymers, and Inorganic Nanomaterials for Therapeutic Applications

  2020cites this paper
• High-Throughput Screening: today's biochemical and cell-based approaches.

  2020cites this paper
• Screening of copper and palladium-mediated reactions compatible with DNA-encoded chemical libraries

  2020cites this paper
• NMR as a “Gold Standard” Method in Drug Design and Discovery

  2020cites this paper
• Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors

  2019cites this paper
• A Library Screening Strategy Combining the Concepts of MS Binding Assays and Affinity Selection Mass Spectrometry

  2019cites this paper
• Screening of copper and palladium-mediated reactions compatible with DNA-encoded chemical libraries.

  2019cites this paper
• Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor.

  2019cites this paper
• Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters

  2018cites this paper
• Quantitative Determination of Protein-Ligand Affinity by Size Exclusion Chromatography Directly Coupled to High-Resolution Native Mass Spectrometry.

  2018cites this paper
• Affinity chromatographic methodologies based on immobilized voltage dependent anion channel isoform 1 and application in protein-ligand interaction analysis and bioactive compounds screening from traditional medicine.

  2017cites this paper
• Simultaneous multiple MS binding assays targeting the monoamine transporters hDAT, hNET, and hSERT

  2017cites this paper
• West Nile Virus

  2016cites this paper
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection

  2016cites this paper
• Engineering strategies for ABD-derived affinity proteins for therapeutic and diagnostic applications

  2016cites this paper
• MS Binding Assays

  2015cites this paper
• Methods for Detection of Small Molecule-Protein Interactions

  2015cites this paper
• An in-silico study: Investigating small molecule modulators of bio-molecular interactions

  2015cites this paper
• What's in a word? The person of personalized (nano)medicine.

  2015cites this paper
• Novel selection methods for DNA-encoded chemical libraries.

  2015cites this paper
• Overview of Recent Progress in Protein-Expression Technologies for Small-Molecule Screening

  2014cites this paper
• Applications of NMR in Drug Discovery

  2014cites this paper
• Exploring therapeutic approaches for treatment of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

  2014cites this paper
• Theoretical Considerations of the Application of DNA‐Encoded Libraries to Drug Discovery

  2014cites this paper
• Using DNA to Program Chemical Synthesis, Discover New Reactions, and Detect Ligand Binding

  2014cites this paper
• Integrated approach to structure-based enzymatic drug design: molecular modeling, spectroscopy, and experimental bioactivity.

  2014cites this paper
• High‐Throughput and ‐Content Screening/Screening for New Pharmaceutics

  2013cites this paper
• Protein-Ligand Interactions

  2013cites this paper
• Bioaffinity sensor based on nanoarchitectonic films: control of the specific adsorption of proteins through the dual role of an ethylene oxide spacer.

  2013cites this paper
• Biophysical methods in drug discovery from small molecule to pharmaceutical.

  2013cites this paper
• Use of Zebrafish Embryos for Small Molecule Screening Related to Cancer

  2013cites this paper
• Flow chemistry approaches directed at improving chemical synthesis

  2013cites this paper
• The integration of flow reactors into synthetic organic chemistry

  2013cites this paper
• Interrogating fragments using a protein thermal shift assay

  2013cites this paper
• Biochemical assays and biophysical tools for inhibitor identification and validation

  2013cites this paper
• Unbiased binding assays for discovering small-molecule probes and drugs.

  2012cites this paper
• Exploiting Ligand-Protein Conjugates to Monitor Ligand-Receptor Interactions

  2012cites this paper
• Analysis of high‐throughput screening assays using cluster enrichment

  2012cites this paper
• Small-molecule discovery from DNA-encoded chemical libraries.

  2011cites this paper
• Characterization and application of a surface modification designed for QCM-D studies of biotinylated biomolecules.

  2011cites this paper
• Non-stoichiometric inhibition in biochemical high-throughput screening

  2011cites this paper
• Interface design and multiplexed analysis with surface plasmon resonance (SPR) spectroscopy and SPR imaging.

  2010cites this paper
• Interaction-Dependent PCR: Identification of Ligand−Target Pairs from Libraries of Ligands and Libraries of Targets in a Single Solution-Phase Experiment

  2010cites this paper
• Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads

  2010cites this paper
• Targeting the undruggable proteome: the small molecules of my dreams.

  2010cites this paper
• ParA: A Novel Target for Anti-Tubercular Drug Discovery

  2010cites this paper
• Training Translators for Smart Drug Discovery

  2010cites this paper
• Lead Selection Overcoming BOTTLENECKS in drug discovery

  2010cites this paper